Celgene

US Medical, Cardiovascular Promotional Review Lead

Posted on: 17 Jan 2021

Princeton, NJ

Job Description

At Bristol Myers Squibb, we are inspired by a single vision transforming patients lives through science. In oncology, hematology, immunology and cardiovascular disease and one of the most diverse and promising pipelines in the industry each of our passionate colleagues contribute to innovations that drive meaningful change. We bring a human touch to every treatment we pioneer. Join us and make a difference.

Responsibilities:

* As a leader in US Medical Promotional Review, creates a high performing, externally focused team which emphasizes cooperation, personal accountability, and a commitment to quality.

* Responsible for providing oversight of the review of promotional materials for scientific/medical validity across BMS Cardiovascular Portfolio.

* Manage a team of medical reviewers, including the recruitment, development and succession planning for talent, while supporting key diversity and inclusion initiatives

* Critically review and provide solutions to complex promotional strategies and tactics to ensure balance of the messages, medical accuracy and appropriateness of the content of the materials/activities in accordance with relevant guidance.

* Proactively align and build strong relationships with commercial leads and other advisors/stakeholders on issues or concerns in promotional review.

* Leverage defined metrics and other tools to improve team performance and ensure adequate resource allocation

* Determine acceptability of data/references used to support promotional claims and provide expert guidance as well as effective negotiation leading to resolution for approval of pieces

* Participate in internal and external meetings (training, educational and others, including medical congresses) to remain current on ever changing regulations, relevant new medical/scientific information and commercial strategy

Qualifications:

* BS degree in scientific and/or medical discipline required; MD, PhD preferred with minimum of 7 years experience in clinical practice or the pharmaceutical industry.

* Previous experience in managing a team preferred

* Demonstrates thorough understanding of medical review of promotional materials in the pharmaceutical industry

* Demonstrated ability to manage various projects, solve problems, deliver on commitments, and work with multidisciplinary teams.

* Strong scientific/medical written and verbal communication skills required.

* In-depth knowledge of the pharmaceutical industry as well as the external compliance, transparency & conflict-of-interest environments

* Experience in delivering a customer-focused service

* Developed business acumen and ability to impact and influence senior internal stakeholders

* Strong leadership and organizational skills with demonstrated success in driving optimal business results in a complex matrix organization required

* Prior experience in therapeutic area preferred

Around the world, we are passionate about making an impact on the lives of patients with serious diseases. Empowered to apply our individual talents and diverse perspectives in an inclusive culture, our shared values of passion, innovation, urgency, accountability, inclusion and integrity bring out the highest potential of each of our colleagues.

Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives.

Celgene

Summit, NJ

Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of cancer and inflammatory diseases worldwide. It offers REVLIMID, an oral immunomodulatory drug for multiple myeloma (MM), myelodysplastic syndromes (MDS), and mantle cell lymphoma; POMALYST/IMNOVID to treat multiple myeloma; OTEZLA, a small-molecule inhibitor of phosphodiesterase 4 for psoriatic arthritis and psoriasis; and ABRAXANE to treat breast, non-small cell lung, pancreatic, and gastric cancers.

The company’s products also include IDHIFA for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (rrAML) with an isocitrate dehydrogenase-2 mutation; VIDAZA, a pyrimidine nucleoside analog for intermediate-2 and high-risk MDS, chronic myelomonocytic leukemia, and AML; THALOMID to treat patients with MM; and ISTODAX, an epigenetic modifier. Its preclinical and clinical-stage product candidates include small molecules, biologics, and cell therapies for immune-inflammatory diseases, myeloid diseases, epigenetics, protein homeostasis, and immuno-oncology.

The company has agreements with BeiGene, Ltd; Acceleron Pharma, Inc.; Agios Pharmaceuticals, Inc.; bluebird bio, Inc.; Lycera Corp.; Juno Therapeutics, Inc.; EXSCIENTIA LTD.; and IMIDomics SL, as well as immuno-oncology collaboration with Sutro Biopharma. Celgene Corporation was founded in 1980 and is headquartered in Summit, New Jersey.